BeStock  
Stocks › Biotechnology › VALN

Valneva VALN

US equityMarket cap rank #3599Biotechnology
$5.16 −$0.21 (-3.82%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $5.16 0.00%
Open$5.30
Prev close$5.37
Day range$5.11 – $5.30
Volume17.6K
Market cap$490.86M
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±5.1%last 16 reports
Closed higher9 of 1656% of the time
Best reaction+21.8%
Worst reaction-10.4%

Stock move on the day after each report

+6.7%2023/Q3-10.4%2023/Q4+0.0%2024/Q1+7.3%2024/Q2-2.0%2024/Q3+7.7%2024/Q4+1.7%2025/Q1+10.6%2025/Q2-2.0%2025/Q3+1.6%2025/Q4-2.2%2026/Q1+1.8%2026/Q2
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q213 Aug 2026Pre Market–+1.80%–
2026/Q113 May 2026Pre Market–-2.17%–
2025/Q418 Mar 2026Pre Market–+1.63%–
2025/Q320 Nov 2025None–-1.95%–
2025/Q212 Aug 2025None–+10.59%–
2025/Q17 May 2025Pre Market–+1.73%–
2024/Q420 Mar 2025None–+7.73%–
2024/Q37 Nov 2024None–-1.97%–
2024/Q213 Aug 2024None–+7.35%–
2024/Q17 May 2024None–+0.00%–
2023/Q420 Mar 2024Pre Market–-10.35%–
2023/Q39 Nov 2023None–+6.67%–
2023/Q221 Sep 2023None–-0.76%–
2023/Q14 May 2023None–+21.84%–
2022/Q423 Mar 2023Pre Market–-2.18%–
2022/Q310 Nov 2022None–+2.33%–

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2025/FY

By business line

  • IXIARO€98.42M 56.3%
  • DUKORAL€31.91M 18.3%
  • Third party products€19.16M 11.0%
  • R&D work and additional support services€9.99M 5.7%
  • IXCHIQ€8.42M 4.8%
  • Milestone payment - licenses€3.42M 2.0%
  • Royalties received€2.12M 1.2%
  • Other non - International Financial Reporting Standards (IFRS) 15 revenue€653,000.00 0.4%
  • Revenues from shipping and handling€481,000.00 0.3%
  • Other€87,000.00 0.0%

By region

  • United States€53.61M 30.7%
  • Canada€30.13M 17.2%
  • Germany€17.47M 10.0%
  • France€14.67M 8.4%
  • Nordics€13.90M 8.0%
  • Other Europe€13.88M 7.9%
  • United Kingdom€12.64M 7.2%
  • Austria€9.47M 5.4%
  • Rest of world€8.90M 5.1%

Latest reported quarter: Q2, ended Jun 2026 · reported in EUR

Revenue€34.94M-27.7% YoY
Operating profit-€26.17M-146.0% YoY
Net profit-€31.20M-169.3% YoY
Diluted EPS-€0.34-142.9% YoY
Free cash flow-€13.77M-240.0% YoY
Operating cash flow-€13.43M

Revenue, last 8 quarters

€45.8MSep '24€52.9MDec '24€49.2MMar '25€48.3MJun '25€29.4MSep '25€47.7MDec '25€30.9MMar '26€34.9MJun '26

Net profit, last 8 quarters

€-9.2MSep '24€-37.0MDec '24€-9.2MMar '25€-11.6MJun '25€-44.4MSep '25€-50.0MDec '25€-32.1MMar '26€-31.2MJun '26

Profitability & balance sheet

Gross margin16.4%
Operating margin-80.4%
Net margin-110.3%
Return on equity-117.8%
Return on assets-36.6%
Return on invested capital-37.9%
Current ratio2.16
Liabilities / assets79.1%
Cash & investments€121.53M
Total debt€207.50M
Net cash (debt)-€85.98M

Discussion

No comments yet — be the first to weigh in on VALN.

Sign in to join the discussion.

Scroll to Top